Jafron Biomedical Co Ltd Financial Flexibility Index
Jafron Biomedical Co Ltd financial flexibility index. Jafron Biomedical Co Ltd (300529) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥64.79 Million (operating CF CN¥35.34 Million minus capex CN¥29.45 Million) represents 0% of total liabilities (CN¥2.11 Billion). Explore reinvestment intensity of Jafron Biomedical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jafron Biomedical Co Ltd (2011–2025)
Financial flexibility index of Jafron Biomedical Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Jafron Biomedical Co Ltd across 15 annual periods. Check 300529 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Jafron Biomedical Co Ltd Financial Flexibility Index by Year (2011–2025)
Jafron Biomedical Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Jafron Biomedical Co Ltd. For the full cash flow conversion analysis, see Jafron Biomedical Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥893.81 Million | CN¥721.22 Million | CN¥1.94 Billion | ▼ -26.5% |
| 2024 | 0.63x | CN¥1.29 Billion | CN¥1.05 Billion | CN¥2.05 Billion | ▲ +28.9% |
| 2023 | 0.49x | CN¥1.16 Billion | CN¥916.74 Million | CN¥2.39 Billion | ▼ -34.7% |
| 2022 | 0.75x | CN¥1.36 Billion | CN¥883.80 Million | CN¥1.82 Billion | ▼ -40.5% |
| 2021 | 1.25x | CN¥1.79 Billion | CN¥1.25 Billion | CN¥1.43 Billion | ▼ -63.5% |
| 2020 | 3.43x | CN¥1.31 Billion | CN¥957.49 Million | CN¥383.06 Million | ▲ +38.3% |
| 2019 | 2.48x | CN¥804.17 Million | CN¥583.50 Million | CN¥324.13 Million | ▲ +46.8% |
| 2018 | 1.69x | CN¥557.60 Million | CN¥384.08 Million | CN¥330.04 Million | ▲ +9.0% |
| 2017 | 1.55x | CN¥481.82 Million | CN¥304.10 Million | CN¥310.90 Million | ▼ -13.4% |
| 2016 | 1.79x | CN¥207.29 Million | CN¥178.64 Million | CN¥115.81 Million | ▼ -16.3% |
| 2015 | 2.14x | CN¥266.58 Million | CN¥205.18 Million | CN¥124.61 Million | ▼ -8.1% |
| 2014 | 2.33x | CN¥201.64 Million | CN¥137.35 Million | CN¥86.59 Million | ▼ -3.3% |
| 2013 | 2.41x | CN¥196.47 Million | CN¥133.33 Million | CN¥81.60 Million | ▼ -29.7% |
| 2012 | 3.42x | CN¥173.68 Million | CN¥120.25 Million | CN¥50.74 Million | ▲ +14.6% |
| 2011 | 2.99x | CN¥91.64 Million | CN¥77.06 Million | CN¥30.68 Million | — |